Learning Objective: Learners will be able to identify clinical signs of reduced neuronal excitability, analyze underlying physiological causes, and correlate ion disturbances, demyelination, toxins, and NMJ disorders with their clinical presentations.
Decreased neuronal excitability or impaired conduction disrupts normal sensory and motor function. These abnormalities may arise from electrolyte imbalances, structural nerve damage, neuromuscular junction (NMJ) disorders, or exposure to neurotoxins. Recognizing these mechanisms helps in diagnosing conditions presenting with weakness, sensory changes, and impaired reflexes.
Clinical Signs
Common signs associated with reduced neural excitability or conduction include:
- Weakness
- Ataxia (loss of coordinated movement)
- Hyporeflexia or areflexia
- Paralysis
- Sensory deficits
These manifestations vary depending on whether the problem is neuronal, axonal, myelin-related, or neuromuscular junction–related.
Causes of Decreased Neuronal Excitability
Major Categories Contributing to Reduced Neuronal Excitability
| Category | Example Conditions / Agents | Mechanism |
|---|---|---|
| Ion Disturbances | Hypokalemia | Hyperpolarizes cells → ↓ excitability |
| Chronic hyperkalemia | Depolarizes but inactivates Na⁺ channels → ↓ firing | |
| Hypercalcemia | Raises threshold → ↓ neuronal firing | |
| Loss of Neurons / Demyelination | Guillain–Barré syndrome | Autoimmune demyelination → slowed conduction |
| Amyotrophic lateral sclerosis (ALS) | Loss of motor neurons → progressive weakness | |
| Aging | Gradual axonal loss + decreased myelin integrity | |
| Toxins / Drugs | Local anesthetics (e.g., lidocaine) | Block voltage-gated Na⁺ channels → conduction block |
| Tetrodotoxin (TTX) | Binds Na⁺ channels → complete block | |
| Saxitoxin (STX) | Toxin similar to TTX → blocks Na⁺ channels | |
| Neuromuscular Junction Disorders | Depolarizing NM blockers (e.g., succinylcholine) | Persistent depolarization → desensitization paralysis |
| Non-depolarizing NM blockers | Competitive blockade of NM receptors | |
| Lambert–Eaton syndrome | Autoantibodies block presynaptic Ca²⁺ channels → ↓ ACh release | |
| Myasthenia gravis | Autoantibodies destroy NM receptors → ↓ postsynaptic response | |
| Botulinum toxin | Blocks ACh release → flaccid paralysis |
Activity
High-Yield Notes
- Na⁺ channel blockers (e.g., TTX, STX, local anesthetics) → stop action potentials entirely.
- Demyelination increases capacitance and decreases conduction velocity → weakness and areflexia.
- NMJ disorders affect transmission but sensation is preserved (important diagnostic clue).
- Electrolyte disturbances can shift resting membrane potential → impair excitability.
- ALS affects upper and lower motor neurons, while GBS affects peripheral myelin.
Clinical Integration
Decreased excitability produces predictable clinical patterns:
- Generalized weakness → think systemic cause (e.g., electrolytes, toxins).
- Ascending paralysis → consider Guillain–Barré.
- Fatigable weakness → suspect myasthenia gravis.
- Improves with activity → suggests Lambert–Eaton syndrome.
- Sudden flaccid paralysis following ingestion of pufferfish → TTX toxicity.
